Publications by authors named "Michael Seiberling"

Claim this Profile
H
Humoral immunity and delayed-type hypersensitivity in healthy subjects treated for 30 days with MK-7123, a selective CXCR2 antagonist.
Michael Seiberling, Thierry Kamtchoua, Paul Stryszak, Xuewen Ma, Ronald B Langdon

Int Immunopharmacol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults.
Michael Seiberling, Monica Bologa, Roger Brookes, Martina Ochs, Kerry Go

Vaccine· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of an oral suspension of VP20621, spores of nontoxigenic Clostridium difficile strain M3, in healthy subjects.
Stephen A Villano, Michael Seiberling, Walter Tatarowicz, Elizabeth Monnot-Chase, Dale N Gerding

Antimicrob Agents Chemother· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absorption, distribution, metabolism, and excretion of macitentan, a dual endothelin receptor antagonist, in humans.
Shirin Bruderer, Gérard Hopfgartner, Michael Seiberling, Janine Wank, Patricia N Sidharta

Xenobiotica· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism, excretion, and pharmacokinetics of [14c]-radiolabeled aleglitazar: a phase I, nonrandomized, open-label, single-center, single-dose study in healthy male volunteers.
Stefan Sturm, Michael Seiberling, Idelette Weick, Axel Paehler, Christoph Funk

Clin Ther· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human pharmacokinetics and safety profile of finafloxacin, a new fluoroquinolone antibiotic, in healthy volunteers.
Heena Patel, Arne Andresen, Andreas Vente, Hans-Dietrich Heilmann, Will Stubbings, Michael Seiberling

Antimicrob Agents Chemother· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of calcium-vitamin D(3) chewable tablets: a single-blind, multiple-dose study in postmenopausal women.
Edgar A Mueller, Michael Seiberling, Wilhelm Kirch, Adrian Frentzel, Sonja Trapp

Expert Opin Drug Metab Toxicol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sotrastaurin and tacrolimus coadministration: effects on pharmacokinetics and biomarker responses.
John M Kovarik, Sylvie Stitah, Alan Slade, Alessandra Vitaliti, Frank Straube, Michael Seiberling

J Clin Pharmacol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sotrastaurin and cyclosporine drug interaction study in healthy subjects.
John M Kovarik, Sylvie Stitah, Alan Slade, Alessandra Vitaliti, Frank Straube, Michael Seiberling

Biopharm Drug Dispos· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety profile of the human anti-Pseudomonas aeruginosa serotype O11 immunoglobulin M monoclonal antibody KBPA-101 in healthy volunteers.
Hedvika Lazar, Michael P Horn, Adrian W Zuercher, Martin A Imboden, Peter Durrer, Michael Seiberling

Antimicrob Agents Chemother· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.
Valérie Künzi, Jaco M Klap, Michael K Seiberling, Christian Herzog, Katharina Hartmann

Vaccine· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of oral posaconazole on the pharmacokinetics of sirolimus.
Allen Moton, Lei Ma, Gopal Krishna, Monika Martinho, Michael Seiberling

Curr Med Res Opin· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers.
Gopal Krishna, Allen Moton, Lei Ma, Ishani Savant, Monika Martinho, Michael Seiberling

Clin Ther· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults.
Isabel Leroux-Roels, Eva Vets, Ralf Freese, Michael Seiberling, Françoise Weber

Vaccine· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absorption, distribution, metabolism, and elimination of the direct renin inhibitor aliskiren in healthy volunteers.
Felix Waldmeier, Ulrike Glaenzel, Bernard Wirz, Lukas Oberer, Dietmar Schmid, Michael Seiberling

Drug Metab Dispos· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability, safety and pharmacokinetics of the FGLL peptide, a novel mimetic of neural cell adhesion molecule, following intranasal administration in healthy volunteers.
Ravi Anand, Michael Seiberling, Thierry Kamtchoua, Rolf Pokorny

Clin Pharmacokinet· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism and disposition of imatinib mesylate in healthy volunteers.
Hans-Peter Gschwind, Ulrike Pfaar, Felix Waldmeier, Markus Zollinger, Claudia Sayer, Michael Seiberling

Drug Metab Dispos· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic interaction between ketoconazole and imatinib mesylate (Glivec) in healthy subjects.
Catherine Dutreix, Bin Peng, Guenther Mehring, Michael Hayes, Renaud Capdeville, Michael Seiberling

Cancer Chemother Pharmacol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic interaction between ezetimibe and lovastatin in healthy volunteers.
Larisa Reyderman, Teddy Kosoglou, Tanya Boutros, Michael Seiberling, Paul Statkevich

Curr Med Res Opin· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects.
Ann E Bolton, Bin Peng, Martine Hubert, Axel Krebs-Brown, Renaud Capdeville, Michael Seiberling

Cancer Chemother Pharmacol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute bioavailability of imatinib (Glivec) orally versus intravenous infusion.
Bin Peng, Catherine Dutreix, Gunther Mehring, Michael J Hayes, Monique Ben-Am, Michael Seiberling

J Clin Pharmacol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis